Legal & General Group Plc - AEGLEA BIOTHERAPEUTICS INC ownership

AEGLEA BIOTHERAPEUTICS INC's ticker is AGLE and the CUSIP is 00773J103. A total of 71 filers reported holding AEGLEA BIOTHERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Legal & General Group Plc ownership history of AEGLEA BIOTHERAPEUTICS INC
ValueSharesWeighting
Q2 2022$2,000
-75.0%
3,2640.0%0.00%
Q1 2022$8,000
-50.0%
3,2640.0%0.00%
Q4 2021$16,000
-38.5%
3,2640.0%0.00%
Q3 2021$26,000
+13.0%
3,2640.0%0.00%
Q2 2021$23,000
-39.5%
3,264
-31.6%
0.00%
Q1 2021$38,0000.0%4,773
-2.1%
0.00%
Q4 2020$38,000
+8.6%
4,8770.0%0.00%
Q3 2020$35,000
-43.5%
4,877
-26.9%
0.00%
Q2 2020$62,000
+264.7%
6,670
+86.0%
0.00%
Q1 2020$17,000
-54.1%
3,586
-25.2%
0.00%
Q4 2019$37,000
+2.8%
4,797
+2.9%
0.00%
Q3 2019$36,000
+20.0%
4,6610.0%0.00%
Q2 2019$30,000
+11.1%
4,661
+37.5%
0.00%
Q1 2019$27,000
+50.0%
3,391
+39.7%
0.00%
Q4 2018$18,000
-21.7%
2,4280.0%0.00%
Q3 2018$23,000
-11.5%
2,4280.0%0.00%
Q2 2018$26,0002,4280.00%
Other shareholders
AEGLEA BIOTHERAPEUTICS INC shareholders Q1 2020
NameSharesValueWeighting ↓
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO 340,679$3,604,0001.39%
Nantahala Capital Management 2,213,052$23,414,0000.95%
SCP Investment, LP 156,137$1,652,0000.82%
SPHERA FUNDS MANAGEMENT LTD. 509,118$5,386,0000.74%
DELTEC ASSET MANAGEMENT LLC 151,781$1,606,0000.32%
Rock Springs Capital Management LP 650,000$6,877,0000.26%
Orbimed Advisors 1,865,524$19,737,0000.24%
Baker Brothers Advisors 1,387,872$14,684,0000.11%
EAM Investors, LLC 56,726$600,0000.10%
Stanley-Laman Group, Ltd. 35,036$371,0000.08%
View complete list of AEGLEA BIOTHERAPEUTICS INC shareholders